Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
|---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis
Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about Sotera Health Company
Sotera Health Company News
Sotera Health Company Quantitative Score
About Sotera Health Company
Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries. It serves medical devices; pharmaceuticals; food and agricultural products; and commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2017 and is headquartered in Broadview Heights, Ohio.
Sotera Health Company Earnings & Revenue
What’s This Company Really Worth? Find Out Instantly.
Warren Buffett’s go-to valuation method is Discounted Cash Flow (DCF). Our tool makes it effortless — no spreadsheets, just answers in a few clicks.
Sotera Health Company Financials
Table Compare
Compare SHC metrics with: | |||
|---|---|---|---|
Earnings & Growth | SHC | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | SHC | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | SHC | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | SHC | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
Sotera Health Company Income
Sotera Health Company Balance Sheet
Sotera Health Company Cash Flow
Sotera Health Company Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
| Metrics | Score |
|---|---|
| Discounted Cash Flows | Strong Sell |
| Return on Equity | Neutral |
| Return on Assets | Neutral |
| Debt/Equity Ratio | Strong Sell |
| Price/Earnings Ratio | Strong Sell |
| Price/Book Ratio | Strong Sell |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
Historical Market Cap
Shares Outstanding
Sotera Health Company Executives
| Name | Role |
|---|---|
| Mr. Michael B. Petras Jr. | Chairman & Chief Executive Officer |
| Mr. Michael P. Rutz | President of Sterigenics |
| Mr. Jonathan M. Lyons | Senior Vice President & Chief Financial Officer |
| Mr. Alexander Dimitrief J.D. | Senior Vice President, General Counsel & Secretary |
| Mr. Joseph A. Shrawder | President of Nelson Labs |
| Name | Role | Gender | Date of Birth | Pay |
|---|---|---|---|---|
| Mr. Michael B. Petras Jr. | Chairman & Chief Executive Officer | Male | 1969 | 2.39M |
| Mr. Michael P. Rutz | President of Sterigenics | Male | 1971 | 1.48M |
| Mr. Jonathan M. Lyons | Senior Vice President & Chief Financial Officer | Male | 1978 | 937.58K |
| Mr. Alexander Dimitrief J.D. | Senior Vice President, General Counsel & Secretary | Male | 1959 | 889.61K |
| Mr. Joseph A. Shrawder | President of Nelson Labs | Male | -- |
Sotera Health Company Insider Trades
| Date | 22 May |
| Name | Flynn Karen |
| Role | Director |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 19132 |
| Date | 22 May |
| Name | Knauss Robert Brown |
| Role | Director |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 19132 |
| Date | 22 May |
| Name | Wheadon David E. |
| Role | Director |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 19132 |
| Date | 22 May |
| Name | PETRELLA VINCENT K |
| Role | Director |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 19132 |
| Date | 22 May |
| Name | Neary James |
| Role | Director |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 19132 |
| Date | Name | Role | Transaction | Type | Shares |
|---|---|---|---|---|---|
| 22 May | Flynn Karen | Director | Acquired | A-Award | 19132 |
| 22 May | Knauss Robert Brown | Director | Acquired | A-Award | 19132 |
| 22 May | Wheadon David E. | Director | Acquired | A-Award | 19132 |
| 22 May | PETRELLA VINCENT K | Director | Acquired | A-Award | 19132 |
| 22 May | Neary James | Director | Acquired | A-Award | 19132 |